In vivo, we showed that ML120B: CHOP combination was well tolerated by the animals and induced higher anti-tumor efficacy compared with each agent alone in our WSU-DLCL2-SCID model (Figure 8). This evidence concerns the gene DDIT3 and neoplasm.